Journal Information
Vol. 28. Issue 6.
Pages 257-259 (August - September 1992)
Vol. 28. Issue 6.
Pages 257-259 (August - September 1992)
Full text access
Betaagonistas y su influencia en la morbimortalidad por asma. Un problema tipo guadiana
Visits
3422
C. Picado
Servei de Pneumologia Hospital Clínic. Facultat de Medicina. Barcelona
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
F.E. Speizer, R. Doll, P. Heaf.
Observations on recent increase in mortality from asthma.
Br Med J, 1 (1968), pp. 335-339
[2.]
F.E. Speizer, R. Doll, P. Heaf.
Investigation into use of drugs preceding death from asthma.
Br Med J, 1 (1968), pp. 339-343
[3.]
P.D. Stolley.
Why the United States was spared an epidemic of deaths due to asthma.
Am Rev Respir Dis, 105 (1972), pp. 883-890
[5.]
S.F. Lanes, A.M. Walker.
Do pressurized bronchodilator aerosols cause death among asthmatics?.
Am J Epidemiol, 125 (1987), pp. 755-760
[6.]
J.M. Esdaile, A.R. Feinstein, R.I. Horwitz.
A repraisal of the United Kingdom epidemic of fatal asthma.
Arch Intern Med, 147 (1987), pp. 543-549
[7.]
J.D. Wilson, D.C. Sutherland, A.C. Thomas.
Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma?.
Lancet, 1 (1981), pp. 1.235-1.237
[8.]
R.T. Jackson, R. Beaglehole, H.H. Rea, et al.
Mortality from asthma: a new epidemic in New Zeeland.
Br Med J, 285 (1982), pp. 771-777
[9.]
I.W.B. Grant.
Asthma in New Zeeland.
Br Med J, 286 (1983), pp. 374-377
[10.]
G. Keating, E.A. Mitchell, R. Jackson, et al.
Trends in sales of drugs for asthma in New Zeeland. Australia and the United Kingdom, 1975-81.
Br Med J, 289 (1984), pp. 348-351
[11.]
M.R. Sears, H.H. Rea, R. Beaglehole, et al.
Asthma mortality in New Zeeland: a two year national study.
NZ Med J, 98 (1985), pp. 271-275
[12.]
M.R. Sears, R. Beaglehole.
Asthma morbidity and mortality: New Zeeland.
J Allergy Clin Immunol, 80 (1987), pp. 383-388
[13.]
J. Crane, N. Pearce, A. Flatt, et al.
Prescribed fenoterol and death from asthma in New Zeeland, 1981-1983: a case-control study.
Lancet, 1 (1989), pp. 917-922
[14.]
T.V. O’Donell, P. Holst, H.H. Rea, M.R. Sears.
Fenoterol and fatal asthma.
Lancet, 2 (1989), pp. 41
[15.]
N.E. Pearce, J. Grainger, M. Atkinson, et al.
Case-control study of prescribed fenoterol and death from asthma in New Zeeland, 1977-1981.
Thorax, 45 (1990), pp. 170-175
[16.]
J. Grainger, K. Woodman, N.E. Pearce, et al.
Prescribed fenoterol and death from asthma in New Zeeland 1981-1987: a further case-control study.
Thorax, 46 (1991), pp. 105
[17.]
M.R. Sears, D.R. Taylor, C.G. Print, et al.
Regular inhaled betaagonist treatment in bronchial asthma.
Lancet, 1 (1990), pp. 1.391-1.396
[18.]
W.O. Speizer, S. Suissa, P. Ernst, et al.
The use of B-agonists and the risk of death and near death from asthma.
N Engl J Med, 326 (1992), pp. 501-506
[19.]
Editorial.
Beta-2 agonists in asthma: relief, prevention, morbidity.
Lancet, 1 (1990), pp. 1.411-1.412
[20.]
B. Burrows, M.D. Lebowitz.
The B-agonists dilemma.
N Engl J Med, 326 (1992), pp. 560-561
[21.]
H.S. Nelson, S.J. Szefler, R.J. Martin.
Regular inhaled betaadrenergic agonists in the treatment of bronchial asthma:beneficial or detrimental?.
Am Rev Respir Dis, 144 (1991), pp. 249-250
Copyright © 1992. Sociedad Española de Neumología y Cirugía Torácica